Cargando…

Transthyretin promotes the invasion of combined hepatocellular cholangiocarcinoma by tumor‐associated macrophages

BACKGROUND: Patients with combined hepatocellular‐cholangiocarcinoma (cHCC‐CCA) have limited treatment options and poor prognosis. Tumor‐associated macrophages (TAMs) are the most abundant infiltrating immune cells in the tumor microenvironment and promote tumor stemness, proliferation, invasion and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ke, Kun, Lin, Junqing, Huang, Ning, Yan, Leye, Liao, Rihua, Yang, Weizhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598247/ https://www.ncbi.nlm.nih.gov/pubmed/37688511 http://dx.doi.org/10.1002/cnr2.1888

Ejemplares similares

A meta-analysis comparing hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma
por: Yan, Leye, et al.
Publicado: (2022)

Constitutive TDO2 expression promotes liver cancer progression by an autocrine IL-6 signaling pathway
por: Wu, Zhengzhong, et al.
Publicado: (2021)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)

Treatment of Combined Hepatocellular and Cholangiocarcinoma
por: Leoni, Simona, et al.
Publicado: (2020)

Intrahepatic cholangiocarcinoma induced M2-polarized tumor-associated macrophages facilitate tumor growth and invasiveness
por: Yuan, Hui, et al.
Publicado: (2020)

Prognostic significance of macrophage invasion in hilar cholangiocarcinoma
por: Atanasov, Georgi, et al.
Publicado: (2015)

Outcome of Combined Hepatocellular and Cholangiocarcinoma of the Liver
por: Wang, Jue, et al.
Publicado: (2010)

Exophytic combined hepatocellular carcinoma and cholangiocarcinoma
por: Noh, Sang Jae, et al.
Publicado: (2012)

Current update on combined hepatocellular-cholangiocarcinoma
por: Maximin, Suresh, et al.
Publicado: (2014)

Combined hepatocellular-cholangiocarcinoma in a cow
por: HONDA, Hidetsugu, et al.
Publicado: (2019)

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019)

Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma
por: Auer, Timo Alexander, et al.
Publicado: (2023)

Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma
por: Murugesan, Karthikeyan, et al.
Publicado: (2021)

Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Yang, Jie, et al.
Publicado: (2020)

Combined Hepatocellular Cholangiocarcinomas; Analysis of a Large Database
por: Wachtel, Mitchell S., et al.
Publicado: (2008)

Major flavonoid constituents and short-term effects of Chun Mee tea in rats
por: Wang, Yunsheng, et al.
Publicado: (2014)

MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
por: Sammon, Jennifer, et al.
Publicado: (2018)

Tumor-associated macrophages promote cholangiocarcinoma progression via exosomal Circ_0020256
por: Chen, Shaoyi, et al.
Publicado: (2022)

Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma
por: Saboo, Sachin S., et al.
Publicado: (2011)

Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update
por: Roßner, Florian, et al.
Publicado: (2023)

Contrast-enhanced ultrasound imaging features and clinical characteristics of combined hepatocellular cholangiocarcinoma: comparison with hepatocellular carcinoma and cholangiocarcinoma
por: Zhang, Hai-Chun, et al.
Publicado: (2020)

A multidimensional nomogram combining imaging features and clinical factors to predict the invasiveness and metastasis of combined hepatocellular cholangiocarcinoma
por: Wang, Yi, et al.
Publicado: (2021)

CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma
por: Zhou, Yan, et al.
Publicado: (2022)

Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma
por: Wang, Tao, et al.
Publicado: (2020)

Tumor burden score dictates prognosis of patients with combined hepatocellular cholangiocarcinoma undergoing hepatectomy
por: Deng, Gang, et al.
Publicado: (2023)

A Case of Combined Hepatocellular-Cholangiocarcinoma with Underlying Schistosomiasis
por: Hong, Chang Kyun, et al.
Publicado: (2007)

CD44 expression in patients with combined hepatocellular cholangiocarcinoma
por: Kim, Ryounggo, et al.
Publicado: (2015)

Breast Metastasis From a Combined Hepatocellular–Cholangiocarcinoma
por: Silva, Marco, et al.
Publicado: (2019)

Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma
por: Gera, Shweta, et al.
Publicado: (2017)

Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma
por: Ishii, Takamichi, et al.
Publicado: (2020)

Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach
por: Choi, Joon Hyuk, et al.
Publicado: (2022)

Management of Locally Advanced or Metastatic Combined Hepatocellular Cholangiocarcinoma
por: Zhao, Jemmy, et al.
Publicado: (2023)

Update on Pathologic and Radiologic Diagnosis of Combined Hepatocellular-Cholangiocarcinoma
por: Rhee, Hyungjin, et al.
Publicado: (2021)

Flotillin-2 predicts poor prognosis and promotes tumor invasion in intrahepatic cholangiocarcinoma
por: Xu, Zhiying, et al.
Publicado: (2020)

Liver Transplantation for Incidental Cholangiocarcinoma or Combined Hepatocellular Carcinoma/Cholangiocarcinoma—Own Experiences and Review of the Literature
por: Schwenk, Laura, et al.
Publicado: (2023)

Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends
por: Wang, Jiakun, et al.
Publicado: (2019)

Transthyretin deposition promotes progression of osteoarthritis
por: Matsuzaki, Tokio, et al.
Publicado: (2017)

Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery
por: Hou, Gui‐min, et al.
Publicado: (2021)

Clinicopathological characteristics and prognostic factors in combined hepatocellular carcinoma and cholangiocarcinoma
por: Park, Sang Eun, et al.
Publicado: (2013)

Update on the Genetics of and Systemic Therapy Options for Combined Hepatocellular Cholangiocarcinoma
por: Azizi, Alexander A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oa5l7snck88tidorli69l7v9jp